Home Healthcare Biotechnology Antisense and RNAi Therapeutics Market

Antisense and RNAi Therapeutics Market Size, Share & Trends Analysis Report By Technology (RNA Interference, siRNA, miRNA, Antisense RNA), By Application (Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Renal Diseases, Neurodegenerative Disorders, Genetic Disorders, Infectious Diseases, Others), By Route of Administration (Intravenous Route, Subcutaneous Route, Intrathecal Route, Pulmonary Delivery, Intraperitoneal Injection, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR5849DR | Pages: 150
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Antisense and RNAi Therapeutics Market Size Analysis
    1. Introduction
    2. Antisense and RNAi Therapeutics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Interference
      2. siRNA
      3. miRNA
      4. Antisense RNA
    3. Antisense and RNAi Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Cardiovascular Diseases (CVDs)
      3. Respiratory Disorders
      4. Renal Diseases
      5. Neurodegenerative Disorders
      6. Genetic Disorders
      7. Infectious Diseases
      8. Others
    4. Antisense and RNAi Therapeutics Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous Route
      2. Subcutaneous Route
      3. Intrathecal Route
      4. Pulmonary Delivery
      5. Intraperitoneal Injection
      6. Others
  7. North America Antisense and RNAi Therapeutics Market Size Analysis
    1. Introduction
    2. Antisense and RNAi Therapeutics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Interference
      2. siRNA
      3. miRNA
      4. Antisense RNA
    3. Antisense and RNAi Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Cardiovascular Diseases (CVDs)
      3. Respiratory Disorders
      4. Renal Diseases
      5. Neurodegenerative Disorders
      6. Genetic Disorders
      7. Infectious Diseases
      8. Others
    4. Antisense and RNAi Therapeutics Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous Route
      2. Subcutaneous Route
      3. Intrathecal Route
      4. Pulmonary Delivery
      5. Intraperitoneal Injection
      6. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
  8. Europe Antisense and RNAi Therapeutics Market Size Analysis
    1. Introduction
    2. Antisense and RNAi Therapeutics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Interference
      2. siRNA
      3. miRNA
      4. Antisense RNA
    3. Antisense and RNAi Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Cardiovascular Diseases (CVDs)
      3. Respiratory Disorders
      4. Renal Diseases
      5. Neurodegenerative Disorders
      6. Genetic Disorders
      7. Infectious Diseases
      8. Others
    4. Antisense and RNAi Therapeutics Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous Route
      2. Subcutaneous Route
      3. Intrathecal Route
      4. Pulmonary Delivery
      5. Intraperitoneal Injection
      6. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
  9. APAC Antisense and RNAi Therapeutics Market Size Analysis
    1. Introduction
    2. Antisense and RNAi Therapeutics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Interference
      2. siRNA
      3. miRNA
      4. Antisense RNA
    3. Antisense and RNAi Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Cardiovascular Diseases (CVDs)
      3. Respiratory Disorders
      4. Renal Diseases
      5. Neurodegenerative Disorders
      6. Genetic Disorders
      7. Infectious Diseases
      8. Others
    4. Antisense and RNAi Therapeutics Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous Route
      2. Subcutaneous Route
      3. Intrathecal Route
      4. Pulmonary Delivery
      5. Intraperitoneal Injection
      6. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    10. Singapore
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
  10. Middle East and Africa Antisense and RNAi Therapeutics Market Size Analysis
    1. Introduction
    2. Antisense and RNAi Therapeutics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Interference
      2. siRNA
      3. miRNA
      4. Antisense RNA
    3. Antisense and RNAi Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Cardiovascular Diseases (CVDs)
      3. Respiratory Disorders
      4. Renal Diseases
      5. Neurodegenerative Disorders
      6. Genetic Disorders
      7. Infectious Diseases
      8. Others
    4. Antisense and RNAi Therapeutics Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous Route
      2. Subcutaneous Route
      3. Intrathecal Route
      4. Pulmonary Delivery
      5. Intraperitoneal Injection
      6. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
  11. LATAM Antisense and RNAi Therapeutics Market Size Analysis
    1. Introduction
    2. Antisense and RNAi Therapeutics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. RNA Interference
      2. siRNA
      3. miRNA
      4. Antisense RNA
    3. Antisense and RNAi Therapeutics Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Oncology
      2. Cardiovascular Diseases (CVDs)
      3. Respiratory Disorders
      4. Renal Diseases
      5. Neurodegenerative Disorders
      6. Genetic Disorders
      7. Infectious Diseases
      8. Others
    4. Antisense and RNAi Therapeutics Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous Route
      2. Subcutaneous Route
      3. Intrathecal Route
      4. Pulmonary Delivery
      5. Intraperitoneal Injection
      6. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. RNA Interference
        2. siRNA
        3. miRNA
        4. Antisense RNA
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases (CVDs)
        3. Respiratory Disorders
        4. Renal Diseases
        5. Neurodegenerative Disorders
        6. Genetic Disorders
        7. Infectious Diseases
        8. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous Route
        2. Subcutaneous Route
        3. Intrathecal Route
        4. Pulmonary Delivery
        5. Intraperitoneal Injection
        6. Others
  12. Competitive Landscape
    1. Antisense and RNAi Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. GSK plc
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Olix Pharmaceuticals, Inc.
    3. Sanofi
    4. Alnylam Pharmaceuticals, Inc.
    5. Arbutus Biopharma
    6. Benitec Biopharma Inc.
    7. Silence Therapeutics
    8. Ionis Pharmaceuticals, Inc
    9. Sarepta Therapeutics
    10. Percheron Therapeutics Limited
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.